ITPR2 and chronic kidney disease: ELISA assessment of the serum ITPR2 levels revealed a significantly decrease in rats in the CKD group at 4 weeks and a slightly increasing trend without statistical difference at 16 weeks compared to rats in the sham group (Figure 7(c)).